ArticleThe Journal of international medical research2021
Risk factors of contrast-induced nephropathy after percutaneous coronary intervention: a retrospective analysis.
Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Artificial intelligence in contrast-induced nephropathy after coronary interventions: A meta-analysis.Medicine · 2026Pooled it
- Preventing Contrast-Induced Acute Kidney Injury in Egyptian Patients Undergoing Coronary Angiography: A Randomized Controlled Trial.Clinical drug investigation · 2026Trial
- Research progress on risk factors and early predictors of contrast-induced nephropathy.American journal of translational research · 2026Review
- Impact of contrast-induced acute kidney injury on patients with acute coronary syndrome: results of a prospective cohort.Frontiers in cardiovascular medicine · 2026Article
- Predictive Value of Urinary KIM-1, TIMP-2 and sTREM-1 for Contrast-Induced Acute Kidney Injury in Elderly Patients After Percutaneous Coronary Intervention.International journal of general medicine · 2025Article
- MehranPeerJ · 2025Article
- Review
- The Agatston score is a predictor of contrast-induced nephropathy in patients with stable coronary artery disease after percutaneous coronary intervention.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2024Article
- Assessing contrast-induced nephropathy risk in older adults undergoing coronary angiography and intervention: The CV/GFR ratio versus Mehran score.SAGE open medicine · 2024Article
- Intravascular Imaging in Ultra-Low or Zero-Contrast Percutaneous Coronary Interventions: The Time Is Now?Journal of clinical medicine · 2023Review
- Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy).Pharmaceuticals (Basel, Switzerland) · 2023Review
- Predictive Value of Hyperuricemia in Cardiac Patients with Post-Contrast Acute Kidney Injury (PC-AKI) and Different Basic Renal Functions: A Meta-Analysis.Iranian journal of public health · 2022Review
- Is the contemporary care of the older persons with acute coronary syndrome evidence-based?European heart journal open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveContrast-induced nephropathy (CIN) is a serious complication in patients with acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI). This study aimed to analyze the potential risk factors for CIN in patients undergoing PCI.
methodsPatients with ACS who underwent PCI treatment from January 2017 to January 2020 were selected. The patients' characteristics and medical information were collected and compared.
resultsA total of 1331 patients undergoing PCI were included. The incidence of CIN was 15.33%. Logistic regression analyses showed that a left ventricular ejection fraction ≤45% (odds ratio [OR] 4.18, 95% confidence interval [CI] 1.10-7.36), serum creatinine levels ≤60 μmol/L (OR 3.03, 95% CI 1.21-5.57), age ≥65 years (OR 2.75, 95% CI 1.32-4.60), log N-terminal pro-B-type natriuretic peptide levels ≥2.5 pg/mL (OR 2.31, 95% CI 1.18-5.13), uric acid levels ≥350 μmol/L (OR 2.29, 95% CI 1.04-5.30), emergency percutaneous intervention (OR 1.35, 95% CI 0.34-3.12), and triglyceride levels ≤1.30 mmol/L (OR 1.10, 95% CI 0.01-2.27) were independent risk factors for CIN in patients who underwent PCI.
conclusionsEarly prevention is required to reduce the occurrence of CIN in patients who undergo PCI and have risk factors for CIN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.